type 2 diabetes

Will Fractyl be Successful in Eliminating the Need for Daily Insulin?
Will Fractyl be Successful in Eliminating the Need for Daily Insulin?
Medical Devices and Diagnostics Industry
devices
Fractyl Labs
insulin
type 2 diabetes
Revita DMR
DMR
Flag link:
Lilly's tirzepatide beats Novo's semaglutide in diabetes phase 3, but another study muddies picture
Lilly's tirzepatide beats Novo's semaglutide in diabetes phase 3, but another study muddies picture
Fierce Biotech
Eli Lilly
Novo Nordisk
tirzepatide
semaglutide
type 2 diabetes
clinical trials
Flag link:
Lilly's tirzepatide aces 2 more late-phase diabetes trials
Lilly's tirzepatide aces 2 more late-phase diabetes trials
Fierce Biotech
Eli Lilly
tirzepatide
type 2 diabetes
clinical trials
Flag link:
Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes
Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes
Yahoo/Global Newswire
Novo Nordisk
FDA
Ozempic
type 2 diabetes
semaglutide
Flag link:
Lilly's Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes
Lilly's Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes
Drugs.com
Eli Lilly
tirzepatide
clinical trials
type 2 diabetes
diabetes
Flag link:
Lilly's tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3
Lilly's tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3
Fierce Biotech
Eli Lilly
tirzepatide
type 2 diabetes
clinical trials
Flag link:
Dexcom takes no-fingerprick message to people with Type 2 diabetes in new TV ads
Dexcom takes no-fingerprick message to people with Type 2 diabetes in new TV ads
Fierce Pharma
DexCom
DTC advertising
diabetes
type 2 diabetes
blood glucose monitoring
Flag link:
Novo launches type 2 diabetes pill in UK after NICE waives review
Novo launches type 2 diabetes pill in UK after NICE waives review
Pharmaforum
Novo Nordisk
UK
type 2 diabetes
diabetes
Rybelsus
semaglutide
NICE
Flag link:
Study: Type 2 Diabetes Treatments May Be More Effective When Combined
Study: Type 2 Diabetes Treatments May Be More Effective When Combined
BioSpace
diabetes
type 2 diabetes
FGF21
GLP-1 agonist
Flag link:
ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar
ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar
Fierce Pharma
ADA
diabetes
Sanofi
Soliqua
type 2 diabetes
Flag link:
Fractyl Seeks to Turn Diabetes On Its Ear with Revita DMR
Fractyl Seeks to Turn Diabetes On Its Ear with Revita DMR
Medical Devices and Diagnostics Industry
Fractyl Labs
diabetes
type 2 diabetes
Revita DMR
devices
Medtech
Flag link:
Sanofi culls pipeline dud, still looking to out-license unwanted later-stage meds
Sanofi culls pipeline dud, still looking to out-license unwanted later-stage meds
Fierce Biotech
Sanofi
Regeneron
efpeglenatide
type 2 diabetes
Flag link:
FDA Revamps Safety Testing for new Type 2 Diabetes Drugs
FDA Revamps Safety Testing for new Type 2 Diabetes Drugs
RAPS.org
FDA
type 2 diabetes
Flag link:
Trulicity gets FDA nod for reducing CV risk in type 2 diabetes patients
Trulicity gets FDA nod for reducing CV risk in type 2 diabetes patients
Pharmaceutical Business Review
Eli Lilly
Trulicity
FDA
type 2 diabetes
Cardiovascular
Flag link:
Preclinical Data Shows Potential Path to Reverse Type-2 Diabetes and Liver Fibrosis
Preclinical Data Shows Potential Path to Reverse Type-2 Diabetes and Liver Fibrosis
BioSpace
Yale
type 2 diabetes
liver fibrosis
Flag link:
NDMA in Metformin: FDA Finds Low Levels in Only 2 of 10 Tested Products
NDMA in Metformin: FDA Finds Low Levels in Only 2 of 10 Tested Products
RAPS.org
NDMA
metformin
FDA
type 2 diabetes
diabetes
Flag link:
Novo Nordisk joins with UVA in diabetes digital simulation project
Novo Nordisk joins with UVA in diabetes digital simulation project
Pharmaforum
Novo Nordisk
UVA
R&D
type 2 diabetes
Flag link:
Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint
Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint
Pharmaceutical Business Review
Jardiance
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
chronic heart failure
clinical trials
Flag link:
After Zantac scare, FDA targets generic metformin for carcinogen tests
After Zantac scare, FDA targets generic metformin for carcinogen tests
Fierce Pharma
generics
FDA
type 2 diabetes
metformin
Flag link:
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Fierce Pharma
AstraZeneca
diabetes
type 2 diabetes
heart failure
Flag link:

Pages